Achromobacter xylosoxidans, an emerging pathogen in catheter-related infection in dialysis population causing prosthetic valve endocarditis: A case report and review of literature

Clinical Nephrology

Volumn 71, Issue 3, 2009, Pages 350-354

  Ahmed, M S ^a   Nistal, C ^a   Jayan, R ^a   Kuduvalli, M ^b   Anijeet, H K I ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b Cardiothoracic Center   (United Kingdom)

Author keywords

Achromobacter xylosoxidans; Dialysis catheter; Endocarditis; Prosthetic valve

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; ETRAPENUM; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; TIGECYCLINE; UNCLASSIFIED DRUG;

ACHROMABACTER XYLOSOXIDANS; ACUTE KIDNEY FAILURE; AGED; ANAMNESIS; ANTIBIOTIC RESISTANCE; AORTA VALVE REPLACEMENT; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CASE REPORT; CATHETER INFECTION; CATHETER REMOVAL; CORONARY ARTERY BYPASS GRAFT; DIALYSIS; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEVER; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; HOSPITAL READMISSION; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MORTALITY; POSTOPERATIVE CARE; PROSTHETIC VALVE ENDOCARDITIS; RESPIRATORY FAILURE; SKIN TEST; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; SYSTOLIC HEART MURMUR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ACHROMOBACTER DENITRIFICANS; FATALITY; GRAM NEGATIVE INFECTION; HEART VALVE PROSTHESIS; INDWELLING CATHETER; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; RENAL REPLACEMENT THERAPY; REVIEW;

ACHROMOBACTER DENITRIFICANS; AGED; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; ENDOCARDITIS, BACTERIAL; FATAL OUTCOME; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEART VALVE PROSTHESIS; HUMANS; MALE; RENAL DIALYSIS;

EID: 65449141303     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP71350     Document Type: Article

References (25)

1. Ahn Y, Kim NH, Shin DH et al. Pacemaker lead endocarditis caused by Achromobacter xylosoxidans. J Korean Med Sci. 2004; 19: 291-293.
2. Davis M, Gratten M, Ree GH. Infective endocarditis caused by Actinobacillus actinomycetemcomitans and Achromobacter xylosoxidans. PNG Med J. 1982; 2: 7-11.
3. De Baets F, Schelstraete P, Van Daele S et al. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. J Cyst Fibros. 2007; 6: 75-78; Epub 2006 Jun 21.
4. Duggan JM, Goldstein SJ, Chenoweth CE et al. Achromobacter xylosoxidans bacteraemia: report of four cases and review of the literature. Clin Infect Dis. 1996; 23: 569-576.
5. El-Shahawy MA, Kim D, Gadallah MF. Peritoneal dialysis-associated peritonitis caused by Alcaligenes xylosoxidans. Am J Nephrol. 1998; 18: 452-455.
6. Haqqie SS, Roth M, Bailie GR. Unsuccessful treatment of CAPD peritonitis caused by Alcaligenes xylosoxidans subsp. denitrificans. Ren Fail. 1995; 17: 611-614.
7. Hoen B, Paul-Dauphin A, Hestin D et al. A multicenter prospective study of risk factors for bacteraemia in chronic haemodialysis patients. J Am Soc Nephrol. 1998; 9: 869-876.
8. Hoen B. Infective endocarditis: a frequent disease in dialysis patients. Nephrol Dial Transplant. 2004; 19: 1360-1362.
9. Igra-Siegman Y, Chmel H, Cobbs C. Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol. 1980; 11: 141-145.
10. Ledger SG, Cordy P. Successful treatment of Alcaligenes xylosoxidans in automated peritoneal dialysis-related peritonitis. Perit Dial Int. 2007; 27: 596-598.
11. Lofgren RP, Nelson AE, Crossley KB. Prosthetic valve endocarditis due to Achromobacter xylosoxidans. Am Heart J. 1981; 101: 502.
12. Marr KA, Sexton DJ, Conlon PJ et al. Catheter-related bacteraemia and outcome of attempted catheter salvage in patients undergoing haemodialysis. Ann Intern Med. 1997; 127: 275-277.
13. Martino P, Micozzi A, Venditti M et al. Catheter-related right-sided endocarditis in bone marrow transplant recipients. Rev Infect Dis. 1990; 12: 250-257.
14. McKinley KP, Laundy TJ, Masterton RG. Achromobacter Group B replacement valve endocarditis. J Infect. 1990; 20: 262-263.
15. Melgosa M, Espinazo O, Alonso A et al. Dialysis-associated Alcaligenes xylosoxidans peritonitis: a paediatric case. Perit Dial Int. 2004; 24: 72-75.
16. Morrison AJ Jr, Boyce K. Peritonitis caused by Alcaligenes denitrificans subsp. xylosoxydans: case report and review of the literature. J Clin Microbiol. 1986; 24: 879-881.
17. Nanuashvili A, Kacharava G, Jashiashvili N. Acase of native valve infective endocarditis caused by Alcaligenes xylosoxidans. Euro Surveill. 2007; 12: E070524.2.
18. Pongiglione R, Jannuzzi C. Lethal endocarditis due to Achromobacter in a child affected by congenital aortic valve stenosis. Minerva Pediatr. 1964; 16: 25-34.
19. Reverdy ME, Freney J, Fleurette J et al. Nosocomial colonization and infection by Achromobacter xylosoxidans. J Clin Microbiol. 1984; 19: 140-143.
20. Saad TF. Bacteraemia associated with tunnelled, cuff haemodialysis catheters. Am J Kidney Dis. 1999; 34: 1114-1124.
21. Saiman L, Chen Y, Tabibi S, San Gabriel P et al. Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. J Clin Microbiol. 2001; 39: 3942-3945.
22. Sasaki H, Kawai H, Sawamura T, Takiya H. Acase report of aortic valve and VSD Dacron patch infective endocarditis after VSD patch closure 15 years ago. Nippon Kyobu Geka Gakkai Zasshi. 1993; 41: 1373-1377.
23. Schubert C, Moosa RM. Infective endocarditis in a hemodialysis patient: a dreaded complication. Haemodial Int. 2007; 11: 379-384.
24. Tang S, Cheng CC, Tse KC et al. CAPD-associated peritonitis caused by Alcaligenes xylosoxidans sp. xylosoxidans. Am J Nephrol. 2001; 21: 502-506; Erratum in Am J Nephrol 2002; 22: 90.
25. Tena D, Carranza R, Barberá JR et al. Outbreak of longterm intravascular catheter-related bacteraemia due to Achromobacter xylosoxidans subspecies xylosoxidans in a haemodialysis unit. Eur J Clin Microbiol Infect Dis. 2005; 24: 727-732.